Tumor immune microenvironment characterization and response to anti-PD-1 therapy

por Santarpia, Mariacarmela, Karachaliou, Niki
Publicado 2015

Mechanisms of resistance to osimertinib

por Lazzari, Chiara, Gregorc, Vanesa, Karachaliou, Niki, Rosell, Rafael, Santarpia, Mariacarmela
Publicado 2020

Overview on Therapeutic Options in Uncommon EGFR Mutant Non-Small Cell Lung Cancer (NSCLC): New Lights for an Unmet Medical Need

por Pretelli, Giulia, Spagnolo, Calogera Claudia, Ciappina, Giuliana, Santarpia, Mariacarmela, Pasello, Giulia
Publicado 2023

KRAS driven expression signature has prognostic power superior to mutation status in non‐small cell lung cancer

por Nagy, Ádám, Pongor, Lőrinc Sándor, Szabó, András, Santarpia, Mariacarmela, Győrffy, Balázs
Publicado 2016

Capillary leak syndrome induced by neoadjuvant cisplatin and gemcitabine in a patient with bladder cancer

por Massafra, Marco, Passalacqua, Maria Ilenia, Lupo, Giuseppe, Altavilla, Giuseppe, Santarpia, Mariacarmela
Publicado 2020

Circulating tumor cells can predict the prognosis of patients with non-small cell lung cancer after resection: a retrospective study

por Li, Zhao, Xu, Ke, Tartarone, Alfredo, Santarpia, Mariacarmela, Zhu, Yuming, Jiang, Gening
Publicado 2021

Human endogenous retroviruses and cancer

por Gonzalez-Cao, María, Iduma, Paola, Karachaliou, Niki, Santarpia, Mariacarmela, Blanco, Julià, Rosell, Rafael
Publicado 2016

Activation of viral defense signaling in cancer

por Gonzalez-Cao, Maria, Karachaliou, Niki, Santarpia, Mariacarmela, Viteri, Santiago, Meyerhans, Andreas, Rosell, Rafael
Publicado 2018

Mosaicism in von Hippel-Lindau disease: an event important to recognize

por Santarpia, Libero, Sarlis, Nicholas J, Santarpia, Mariacarmela, Sherman, Steven I, Trimarchi, Francesco, Benvenga, Salvatore
Publicado 2007

Circulating tumor DNA accurately predicts disease progression and genotype alterations in postoperative adjuvant EGFR-TKI resistance: a case report

por Zeng, Zhen, Liu, Chengwu, Deng, Senyi, Lin, Feng, Husain, Hatim, Santarpia, Mariacarmela, Liu, Lunxu
Publicado 2022

One-third of an Archivial Series of Papillary Thyroid Cancer (Years 2007–2015) Has Coexistent Chronic Lymphocytic Thyroiditis, Which Is Associated with a More Favorable Tumor-Node-...

por Ieni, Antonio, Vita, Roberto, Magliolo, Emilia, Santarpia, Mariacarmela, Di Bari, Flavia, Benvenga, Salvatore, Tuccari, Giovanni
Publicado 2017

A narrative review of MET inhibitors in non-small cell lung cancer with MET exon 14 skipping mutations

por Santarpia, Mariacarmela, Massafra, Marco, Gebbia, Vittorio, D’Aquino, Antonio, Garipoli, Claudia, Altavilla, Giuseppe, Rosell, Rafael
Publicado 2021

Understanding the function and dysfunction of the immune system in lung cancer: the role of immune checkpoints

por Karachaliou, Niki, Cao, Maria Gonzalez, Teixidó, Cristina, Viteri, Santiago, Morales-Espinosa, Daniela, Santarpia, Mariacarmela, Rosell, Rafael
Publicado 2015

Management of Endocrine and Metabolic Toxicities of Immune-Checkpoint Inhibitors: From Clinical Studies to a Real-Life Scenario

por Spagnolo, Calogera Claudia, Giuffrida, Giuseppe, Cannavò, Salvatore, Franchina, Tindara, Silvestris, Nicola, Ruggeri, Rosaria Maddalena, Santarpia, Mariacarmela
Publicado 2022

Advances in immunotherapy for treatment of lung cancer

por Bustamante Alvarez, Jean G., González-Cao, María, Karachaliou, Niki, Santarpia, Mariacarmela, Viteri, Santiago, Teixidó, Cristina, Rosell, Rafael
Publicado 2015

Cardiotoxicity Induced by Immune Checkpoint Inhibitors: What a Cardio-Oncology Team Should Know and Do

por Zito, Concetta, Manganaro, Roberta, Ciappina, Giuliana, Spagnolo, Calogera Claudia, Racanelli, Vito, Santarpia, Mariacarmela, Silvestris, Nicola, Carerj, Scipione
Publicado 2022

Neuropsychiatric Adverse Drug Reactions with Tyrosine Kinase Inhibitors in Gastrointestinal Stromal Tumors: An Analysis from the European Spontaneous Adverse Event Reporting System

por Barbieri, Maria Antonietta, Sorbara, Emanuela Elisa, Russo, Giulia, Cicala, Giuseppe, Franchina, Tindara, Santarpia, Mariacarmela, Silvestris, Nicola, Spina, Edoardo
Publicado 2023

Renal Disorders with Oral Tyrosine Kinase Inhibitors in Metastatic Colorectal Cancer: An Analysis from the FDA Adverse Event Reporting System Database

por Russo, Giulia, Barbieri, Maria Antonietta, Sorbara, Emanuela Elisa, Cicala, Giuseppe, Franchina, Tindara, Santarpia, Mariacarmela, Silvestris, Nicola, Spina, Edoardo
Publicado 2023

Coregulation of pathways in lung cancer patients with EGFR mutation: therapeutic opportunities

por Rosell, Rafael, Cardona, Andrés Felipe, Arrieta, Oscar, Aguilar, Andrés, Ito, Masaoki, Pedraz, Carlos, Codony-Servat, Jordi, Santarpia, Mariacarmela
Publicado 2021

Targeting MET in Non-Small Cell Lung Cancer (NSCLC): A New Old Story?

por Spagnolo, Calogera Claudia, Ciappina, Giuliana, Giovannetti, Elisa, Squeri, Andrea, Granata, Barbara, Lazzari, Chiara, Pretelli, Giulia, Pasello, Giulia, Santarpia, Mariacarmela
Publicado 2023